Company profile
Employees
Incorporated
Location
Fiscal year end
Former names
Viracta Therapeutics, INC., HEMAQUEST PHARMACEUTICALS, INC., HEMAQUEST PHARMACEUTICALS
SEC CIK
IRS number
260814473
Latest filings (excl ownership)
D
$65M in equity, sold $65M, 26 investors
10 Mar 21
D
$40M in equity, sold $40M, 14 investors
10 Dec 20
D
$25M in equity, sold $16.77M, 21 investors
5 Nov 19
D/A
$10.7M in equity, sold $10.7M, 6 investors
12 Feb 19
D
$5.71M in equity, sold $5.71M, 25 investors
12 Feb 19
D
$10M in equity, sold $2M, 1 investor
13 Dec 18
D
$8.5M in debt, sold $2.69M, 27 investors
2 Jul 18
D
$26.88M in equity, sold $9.88M, 9 investors
5 Apr 17
D
$16M in equity, sold $6.5M, 10 investors
4 Apr 12
D/A
$16.12M in equity, sold $16.06M, 12 investors
2 Aug 10
Institutional ownership, Q1 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|